The Commercial #Microbiome Market

Now that #SFAF2019 is over and I have a few days to relax in sunny Santa Fe NM, I took some time to do a little reading and writing on some topics I’ve had on my mind lately. Recently at #SFAF2019, I had a chat with a colleague about the size and scope of the microbiome market. I was surprised they didn’t realize how rapidly this space was growing, and how many companies are operating in this space with specific solutions and products for both B2B and B2C markets.

I’ve done a ton of analysis on this topic (far more than just the simple list that is below) – but suffice to say that (depending on your math) there’s well over a billion of dollars of investment funding (VC and otherwise) pouring into this space. The list below includes many startups, as well as larger ones that are either already offering services or products specifically for the microbiome market or making investments in developing new ones.

By no means is this a complete list – I know I probably missed some. Leave a comment and let me know if I’ve missed something. ANd yes – I probably should break these companies into separate categories too, but that would be for a post on another day. The list below includes commerical organizations that produce or are developing therapeutics, diagnostics, B2B and B2C products or services specialized in the microbiome space.

It’s hard to keep up with all of them…

Adapsyn Bioscience
Advanced Biological Laboratories (ABL)
American Gut Project
AOBiome
Aperiomics
AppliedMaths
Ardigen
ARTpred
AsiaBiome
Astarte Medical
Axial Biotherapeutics
Azitra
Bio-Me
BioConsortia
Biome Bliss
Biome Makers
Biomes Metabolon
BiomX
Boost
CD Genomics
CeMeT GmbH
CHAIN Biotechnology
ChunLabs
Clinical Metagenomics A/S
ClostraBio
Commense
Concentric
CoreBiome
CosmosID
DayTwo
Diversigen
Dupont Nutrition & Health
Eligo Bioscience
Enbiome
Enterome
Enterome Bioscience
EpiBiome
Evelo Biosciences
Evolve BioSystems
Farmhouse Culture
Ferring Therapeutics
Finch Therapeutics
Floragraph
FryLabs
Genetech
Genome & Company
Ginko Bioworks
ID Genomics
IDbyDNA
Illumina
Indigo AG
Indigo Agriculture
Inocucor Technologies
Ixcela
Janssen
Kaleido Biosciences
Kallyope
Karius
Leucine Rich Bio
Locus Biosciences
Loop Genomics
Maat Pharma
Metabiota
Metabolon
Metagenome Analytics, LLC
Microbiome Insights
Microbiome Therapeutics
Microbiotica
MicroGen Biotech
MicrogenDX
Naked Biome
NatureMetrics
Nemesis Bioscience
Nextbiotix
Noblis
Norgen Biotek
Noscendo
Novosanis
One Codex
OpenBiome
OraSure
Oxford Nanopore
PacBio
PharmaBiome
Phylagen
Probionase
Promega
QIAGEN Biox
RealTime Genomics
ReBiotix
Reckitt Benckser
Resphera Biosciences
Ritter Pharmaceuticals
Second Genome
Seres Therapeutics
Serlmmune
Seventure
Shoreline Biome
Signature Science
Siolta Therapeutics
Snipr Biome
Sugarlogix
Symbiotix Biotherapies
Taconic
Takeda Pharmaceuticals
TargEDys
TGEN
The BioCollective
ThermoFisher
Thryve
uBiome
Vedanta Biosciences
Viome
WholeBiome
Zymergen
ZymoResearch

Who have I missed?

Published by

Jonathan Jacobs

You can catch up with Jonathan on Twitter (@bioinformer).

8 thoughts on “The Commercial #Microbiome Market”

  1. One new entrant is Probionase Therapies, which produces Probiorinse, the first probiotic designed for application directly inside the nose. This innovative solution is unique and has been on sale to consumers in the US for one year and has launched about four weeks ago in Canada.

    1. Thanks! I’ll add it to my list. I expect that there are far more B2C companies in this space that I’m not aware of – they seem to be cropping up all the time. 😉

  2. Great list Jonathan. Resphera Biosciences also remains active in the microbiome space providing bioinformatics and biostatistical support to research hospitals and groups in industry.

  3. Dear Jonathan, thank you for putting together this extensive list. Here is another company to keep in mind:
    PharmaBiome (www.pharmabiome.com) pioneers next-generation microbiome therapies. Our bacterial mixes target functional disbalances of the microbiome and our portfolio of previously uncultured intestinal bacteria and our proprietary technology allow greater control over production, storage and therapeutic efficacy.

  4. Thanks Jonathan! This is very helpful! Here are some additional companies that I think qualify for the list –
    Armata Pharmaceuticals
    BaseClear BiaNomics
    BiomX
    Biospherex
    Clinical Microbiomics A/S (I think the name Clinical Metagenomics A/S in the list may be incorrect)
    CoreBiome
    DNAgenotek
    Eagle Genomics
    Eurofins
    Locus Biosciences
    Loop Genomics
    Metabiomics
    Microba
    MOgene
    Osel
    Phase Genomics
    Pylum Biosciences
    Rancho Biosciences
    S-Biomedic
    Sun Genomics
    Zymo Research

    VC/Investor – ?
    Seventure Partners
    Johnson & Johnson

    Do you intend to include companies from the following industries: pre/probiotic industry (may double or triple the list), cosmetics and skincare, pet microbiomics?

    1. Yes. I need to refine this list a bit (i’ve removed “suppliers/vendors”) and will update shortly. But consumer focused “microbiome” companies I would consider also on the list.

  5. I’ve updated the post with suggestions I received from Twitter and here in the comments – now up to 116 companies! wow…

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.